Tag:
whistleblower
Latest Headlines
Latest Headlines
Whistleblower says Cephalon ignored DoJ pact to push off-label uses
The allegations in a recently released lawsuit against Cephalon suggest that company was particularly obscene about pushing off-label uses, because at the time it was operating under a Corporate Integrity Agreement forged after getting caught for similar problems a few years earlier.
Whistleblowers claim Warner execs flouted marketing rules
Two former Warner Chilcott reps have blown the whistle. In a False Claims Act lawsuit unsealed last week, the ex-salespeople detail a long series of allegations, including kickbacks, privacy violations and off-label shenanigans.
Amgen whistleblower can't challenge $612M settlement, judge says
One Amgen whistleblower is balking at the government's off-label marketing settlement--but the federal court is having none of it. Dr. Joseph Piacentile, who worked undercover to gather evidence for the prosecutors' case, claims he and other whistleblowers have had no say-so in the settlement, Bloomberg reports. And he wants his day in court.
Amgen whistleblower went undercover for the feds
In Hollywood, when undercover agents are planning to secretly record a meeting, there's often a scene meant to engage the audience's fear and sympathy: "Are you wearing a wire?" someone accuses, usually someone armed with a gun or enormous fists.
UPDATE: Amgen pleads guilty in $762M Aranesp settlement
Amgen's long-brewing settlement with the U.S. Justice Department is close at hand. The drugmaker pleaded guilty today to a misdemeanor misbranding charge for mismarketing its anemia drug Aranesp.
Whistleblower lawsuit on Pfizer's Lipitor dismissed
A federal judge has knocked the breath out of a former Pfizer executive whose whistleblower lawsuit accused the company of using a variety of shenanigans to pedal more scripts of Lipitor, the cholesterol-lowering drug that became the best-selling med of all time.
Indian sales reps strike to demand strict drug-promo rules
In the U.S., pharma sales reps turn whistleblower when they believe their companies are flouting the rules. In India, they apparently go on strike.
Report: Top FDA officials knew of whistleblower email monitoring
The FDA's email monitoring of employees after they testified to Congress about questionable medical device approval practices appears to have been sanctioned all the way to the top, according to The Wall Street Journal.
Sanofi chief among then-GSK execs named in DoJ off-label case
GlaxoSmithKline's $3 billion settlement opened up pages upon pages of Justice Department allegations. And some of those pages name names--well-known names.
Whistleblowers: Merck hid declining efficacy of MMR shot
Two former Merck ($MRK) employees lodged a whistleblower suit against the drugmaker, alleging that it overstated the effectiveness of its MMR vaccine.
